Calamba, Luis V.
HRN: 03-15-18 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/14/2022
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
08/14/2022
08/21/2022
IVT
1.5g
Q6hrs
Nonhealing Wound
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes